e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Genprex, Inc. - Common Stock
(NQ:
GNPX
)
0.2130
+0.0087 (+4.26%)
Streaming Delayed Price
Updated: 12:46 PM EDT, Oct 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Genprex, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
February 11, 2025
Via
Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
November 04, 2024
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10.
Via
Benzinga
Topics
Government
12 Health Care Stocks Moving In Monday's After-Market Session
October 28, 2024
Via
Benzinga
Looking Into Genprex's Recent Short Interest
October 28, 2024
Via
Benzinga
GNPX Stock Earnings: Genprex Reported Results for Q2 2024
August 12, 2024
Genprex just reported results for the second quarter of 2024.
Via
InvestorPlace
GNPX Stock Earnings: Genprex Beats EPS for Q1 2024
May 20, 2024
GNPX stock results show that Genprex beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
October 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 23, 2024
Via
Benzinga
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
October 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 22, 2024
Via
Benzinga
Dow Falls Over 150 Points; General Motors Tops Q3 Views
October 22, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 22, 2024
Via
Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 21, 2024
Via
Benzinga
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
October 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
Planned Spin-Out to Focus on Gene Therapy for Type-1 and Type-2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex, Inc. (Nasdaq: GNPX)
September 04, 2024
Via
Get News
Positive Clinical Results with Promising Gene Therapy Treatment for Late Stage Lung Cancer; Life-Changing Developments for Cancer and Diabetes: Genprex, Inc. (Nasdaq: GNPX)
August 22, 2024
Via
Get News
Topics
Intellectual Property
Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
August 13, 2024
Via
Benzinga
S&P 500 Gains 1%; Home Depot Earnings Top Views
August 13, 2024
Via
Benzinga
Topics
Stocks
Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
August 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 31, 2024
Via
Benzinga
Clinical Trials Commenced for Promising Acclaim-3 Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer: Genprex, Inc. (NASDAQ: GNPX)
May 14, 2024
Via
Get News
New Company Officers Appointed After Promising Preclinical Data on Gene Therapy for Anti-Tumor Mechanisms with Ability to Trigger Cancer Cell Death: Genprex, Inc. (NASDAQ: GNPX)
May 13, 2024
Via
Get News
BioMedNewsBreaks — Genprex Inc. (NASDAQ: GNPX) Announces Participation at Upcoming Investor, Industry Events
May 01, 2024
Via
Investor Brand Network
Topics
Intellectual Property
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 26, 2024
Via
Benzinga
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting NPRL2 Gene Therapy
April 02, 2024
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Facebook
Twitter
YouTube